Navigating the Evolving Landscape of Generalized Anxiety Disorder (GAD) Treatment: From SSRIs to Digital Therapeutics
Generalized Anxiety Disorder (GAD) is a prevalent and often debilitating mental health condition characterized by persistent, excessive worry about everyday events. It affects an estimated 6% of the global population at some point in their lives, translating to a vast patient population driving a significant and growing market. The GAD treatment market is a dynamic…
